Andrew R. Boll Harrow Health, Inc. (HROW) insider trading activity

Andrew R. Boll is PRESIDENT AND CFO of HARROW HEALTH, INC.. Currently has a direct ownership of 811,179 shares of HROW, which is worth approximately $33 Million. The most recent transaction as insider was on Dec 12, 2025, when has been sold 26,665 shares (Common Stock) at a price of $47.06 per share, resulting in proceeds of $1,254,854. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 811K

4.29% 3M change

42.79% 12M change

Total Value Held $33 Million

ANDREW R. BOLL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 12 2025	SELL Payment of exercise price or tax liability	$1,254,854 $47.06 p/Share	26,665 Reduced 3.18%	811,179 Common Stock
Dec 12 2025	BUY Exercise of conversion of derivative security	$237,000 $3.95 p/Share	60,000 Added 6.68%	837,844 Common Stock
Apr 07 2025	SELL Payment of exercise price or tax liability	$3,157,442 $23.09 p/Share	136,745 Reduced 14.95%	777,844 Common Stock
Apr 03 2025	BUY Exercise of conversion of derivative security	-	346,500 Added 27.48%	914,589 Common Stock
Feb 20 2024	SELL Exercise of conversion of derivative security	$197,181 $10.67 p/Share	18,480 Reduced 3.15%	568,089 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	$480,150 $10.67 p/Share	45,000 Added 7.13%	586,569 Common Stock
Feb 07 2024	BUY Exercise of conversion of derivative security	$57,054 $7.71 p/Share	7,400 Added 1.35%	541,569 Common Stock

Jul 18 2023	SELL Payment of exercise price or tax liability	$2,485,660 $18.23 p/Share	136,350 Reduced 20.33%	534,169 Common Stock
Jul 18 2023	BUY Exercise of conversion of derivative security	-	346,500 Added 34.07%	670,519 Common Stock
Mar 31 2023	SELL Payment of exercise price or tax liability	$728,792 $21.16 p/Share	34,442 Reduced 9.61%	324,019 Common Stock
Mar 31 2023	BUY Exercise of conversion of derivative security	$540,000 $6.0 p/Share	90,000 Added 20.07%	358,461 Common Stock
Jan 02 2023	SELL Payment of exercise price or tax liability	$141,725 $14.76 p/Share	9,602 Reduced 3.45%	268,461 Common Stock
Jan 02 2023	BUY Exercise of conversion of derivative security	-	23,000 Added 7.64%	278,063 Common Stock
Dec 22 2022	BUY Open market or private purchase	$33,850 $13.54 p/Share	2,500 Added 0.97%	255,063 Common Stock
Feb 19 2022	SELL Payment of exercise price or tax liability	$162,161 $7.87 p/Share	20,605 Reduced 7.54%	252,563 Common Stock
Feb 19 2022	BUY Exercise of conversion of derivative security	-	50,000 Added 15.47%	273,168 Common Stock
Apr 25 2021	SELL Payment of exercise price or tax liability	$411,612 $8.26 p/Share	49,832 Reduced 18.25%	223,168 Common Stock
Apr 25 2021	BUY Exercise of conversion of derivative security	-	127,500 Added 31.84%	273,000 Common Stock
Feb 25 2021	SELL Payment of exercise price or tax liability	$57,600 $7.68 p/Share	7,500 Reduced 4.9%	145,500 Common Stock
Feb 25 2021	BUY Exercise of conversion of derivative security	-	30,000 Added 16.39%	153,000 Common Stock

ARB

Andrew R. Boll

PRESIDENT AND CFO

Nashville, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HROW shares.

Notify only if

Value

Insider Trading

Get notified when an Harrow Health, Inc. insider buys or sells HROW shares.

Notify only if

Operation

Value

Type

News

Receive news related to HARROW HEALTH, INC.

Track Activities on HROW

Account